UTMB was named a recipient of the 2024 MAP Award for High Performance in Revenue Cycle, sponsored by the Healthcare Financial Management Association. Becker’s reports that “the MAP Award recognizes providers that have excelled in meeting industry standard revenue cycle benchmarks, implemented best practices embodied in HFMA's Healthcare Dollars & Sense initiatives, focused their efforts on improving price transparency, and achieved outstanding patient satisfaction.”

UTMB President Dr. Jochen Reiser spoke to Becker’s about artificial intelligence in health care. “This is clearly with enormous potential, not only for diagnostics but also for operational use, ultimately creating more time for doctors and providers to do what they love to do which is to spend time with the patients,” Reiser told Becker’s.

Have you ever heard of a cancer that could be eliminated by vaccination, ask Drs. Norbert Herzog and David Niesel in their Medical Discovery News column. Human papilloma viruses (HPV) cause 90 percent of cervical cancers, and there is a vaccination to prevent HPV infection yet only 21 percent of people have received it, they write.

While the attention on breast cancer awareness is good, doctors agree that there should be just as much emphasis on women’s heart health. UTMB’s Dr. Fatima Khan tells Flow Space that one of the challenges is that women do not have the same signs and symptoms as men. “Most of the literature in the books and educational material is based on the research done on men, since we did not know for ages that heart disease can also impact women,” says Khan.

UTMB and Texas A&M University are partnering to create tools that replicate female organs involved in pregnancy to allow medical drug testing for pregnant women. “If you go to Walgreens and look at their pharmacy aisle and pick up an over-the-counter drug, it may say ‘not tested in pregnancy,’” Dr. Ramkumar Menon told the Daily News. “We have developed a way to test both the mother and baby in a lab environment.”

The reclassification of marijuana will change the way researchers will be able to study the drug, Dr. Kathryn Cunningham told the Daily News for a story on the U.S. Justice Department’s move to reclassify marijuana as a less dangerous drug. “By reducing it to Schedule III, we would facilitate the research and allow laboratories to gain much more information and knowledge about the impact of marijuana and its constituents on public health,” Cunningham said.

“Overall, the evidence points to higher temperatures resulting in more bird-mosquito transmission and more what we call spillover infections to people,” Dr. Scott Weaver tells Grist for this article on how a changing climate is contributing to the spread of West Nile Virus.